Skip to main content

Table 1 Baseline demographic data of the progression and the non-progression groups

From: Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study

Variables

Progression Group

(n = 198)

Non-progression Group (n = 168)

p value

Age

65.83 ± 11.46

64.74 ± 10.19

0.375

Sex(Man/Women)

158/40

139/29

0.474

BMI (kg/m2)

25.47 ± 3.18

24.80 ± 3.63

0.421

Hypertension (%)

153 (77.3)

121 (72.5)

0.289

Diabetes (%)

85 (42.9)

51 (30.4)

0.013

NGR (%)

67 (33.8)

86 (51.2)

0.001

IFG (%)

13 (6.6)

7 (4.2)

0.362

IGT (%)

20 (10.1)

18 (10.8)

0.865

IFG + IGT (%)

13 (6.6)

6 (3.6)

0.241

Initial admission n (%)

   

ECG abnormalities

24 (12.1)

12 (7.1)

0.111

Stable Angina

29 (14.6)

33 (19.6)

0.204

Unstable Angina

86 (43.4)

70 (41.7)

0.733

Non-ST elevated AMI

10(5.1)

9(5.4)

0.895

ST elevated AMI

49 (24.7)

44 (26.2)

0.752

Medication (%)

   

Statin

196 (99.5)

165 (98.8)

0.468

CCB

67(29.6)

55(32.9)

0.806

ACEI/ARB

104 (53.6)

76 (46.1)

0.154

β-blocker

164 (82.8)

128(76.6)

0.141

Oral glucose lowering dug

70(35.9)

35(21.2)

0.002

Application of insulin

9(4.5)

11(6.5)

0.491